Detection of antibodies against Leptospira serovars via microscopic agglutination tests in dogs in the United States, 2000-2007

Journal of the American Veterinary Medical Association

Volumn 237, Issue 3, 2010, Pages 293-298

  Gautam, Raju ^a,c   Wu, Ching Ching ^a   Guptill, Lynn E ^a   Potter, Adam ^b   Moore, George E ^a  

^a PURDUE UNIVERSITY   (United States)

^b IDEXX LABORATORIES   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

AGGLUTINATION TEST; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CLASSIFICATION; DOG; DOG DISEASE; EPIDEMIOLOGY; IMMUNOLOGY; LEPTOSPIRA; LEPTOSPIROSIS; METHODOLOGY; MICROBIOLOGY; TIME; UNITED STATES;

AGGLUTINATION TESTS; ANIMALS; ANTIBODIES, BACTERIAL; DOG DISEASES; DOGS; LEPTOSPIRA; LEPTOSPIROSIS; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS; UNITED STATES;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; LEPTOSPIRA;

EID: 77955564077     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Farr RW. Leptospirosis. Clin Infect Dis 1995;21:1-6.
2. World Health Organization. Leptospirosis worldwide, 1999. Wkly Epidemiol Rec 1999;74:237-242.
3. Bolin CA. Diagnosis of leptospirosis: a reemerging disease of companion animals. Semin Vet Med Surg (Small Anim) 1996;11:166-171.
4. Greene CE, Miller MA, Brown CA. Leptospirosis. In: Greene CE, ed. Infectious diseases of the dog and cat. 3rd ed. St Louis: Elsevier Inc, 2006;402-416.
5. Harkin KR, Roshto YM, Sullivan JT, et al. Comparison of polymerase chain reaction assay, bacteriological culture, and serologic testing in assessment of prevalence of urinary shedding of leptospires in dogsj Am Vet Med Assoc 2003;222:1230-1233.
6. Ward MP, Glickman LT, Guptill LE Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970-1998). J Am Vet Med Assoc 2002;220:53-58.
7. Morgan J, Bornstein SL, Karpati AM, et al. Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis 2002;34:1593-1599.
8. Levett PN. Leptospirosis. Clin Microbiol Rev 2001;14:296-326.
9. Moore GE, Guptill LF, Glickman NW, et al. Canine leptospirosis, United States, 2002-2004. Emerg Infect Dis 2006;12:501-503.
10. Geisen V, Stengel C, Brem S, et al. Canine leptospirosis infections-clinical signs and outcome with different suspected Leptospira serogroups (42 cases). J Small Anim Pract 2007;48:324-328.
11. Sessions JK, Greene CE. Canine leptospirosis: epidemiology, pathogenesis, and diagnosis. Compend Contin Educ Pract Vet 2004;26:606-623.
12. Brown CA, Robert AW, Miller MA, et al. Leptospira interrogans serovar grippotyphosa infection in dogs. J Am Vet Med Assoc 1996;209:1265-1267.
13. Ward MP, Guptill LF, Prahl A, et al. Serovar-specific prevalence and risk factors for leptospirosis among dogs: 90 cases (1997-2002). J Am Vet Med Assoc 2004;224:1958-1963.
14. Barr SC, McDonough PL, Scipioni-Ball RL, et al. Serologic responses of dogs given a commercial vaccine against Leptospira interrogans serovar pomona and Leptospira kirschneri serovar grippotyphosa. AmJ Vet Res 2005;66:1780-1784.
15. Hartman EG, van Houten M, Frik JF, et al. Humoral immune response of dogs after vaccination against leptospirosis measured by an IgM- and IgG-specific ELISA. Vet Immunol Immunopathol 1984;7:245-254.
16. Stokes JE, Kaneene JB, Schall WD, et al. Prevalence of serum antibodies against six Leptospira serovars in healthy dogs. J Am Vet Med Assoc 2007;230:1657-1664.
17. Kingscote BF. Leptospirosis in red foxes in Ontario. J Wildl Dis 1986;22:475-478.
18. Nielsen JN, Cochran GK, Cassells JA, et al. Leptospira interrogans serovar bratislava infection in two dogs. J Am Vet Med Assoc 1991;199:351-352.
19. Baverud V, Gunnarsson A, Engvall EO, et al. Leptospira seroprevalence and associations between seropositivity, clinical disease and host factors in horses. Acta Vet Scand 2009;51:15-24.
20. Dong H, Hu Y, Xue F, et al. Characterization of the ompLl gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpLl protein. BMC Microbiol 2008;8:223-234.
21. Murray GL, Srikram A, Hoke DE, et al. The major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect Immun 2009;77:952-958.
22. Somier C, Branger C, Michel V, et al. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine 2000;19:86-94.
23. Ward ME Seasonality of canine leptospirosis in the United States and Canada and its association with rainfall. Prev Vet Med 2002;56:203-213.
24. Mitchell MA, Hungerford LL, Nixon C, et al. Serologic survey for selected infectious disease agents in raccoons from Illinois. J Wildl Dis 1999;35:347-355.
25. Richardson DJ, Gauthier JL. A serosurvey of leptospirosis in Connecticut peridomestic wildlife. Vector Borne Zoonotic Dis 2003;3:187-193.
26. Gehrt SD. Raccoon. In: Feldhamer GA, Thompson BC, Chapman CA, eds. Wild mammals of North America: biology, management, and conservation. Baltimore: Johns Hopkins University Press, 2003;611-634.
27. Alton GD, Berke O, Reid-Smith R, et al. Increase in seroprevalence of canine leptospirosis and its risk factors, Ontario 1998-2006. Can] Vet Res 2009;73:167-175.